baber/WOPTO huggingface dataset:
Patent JP-2001522472-A (JP)
Title: 金属層および誘電層から成る吸収性薄膜システム
IPC: G02B5/22
Filed: 1998-03-20
Abstract: (57)【要約】
吸収性薄膜システムが提案される。この薄膜システムは交互の金属層と誘電層から形成される。この構成により、可視スペクトル領域において中性な色吸収特性と、所定の位相シフト並びに所定の透過率が実現される。この層システムは、顕微鏡のコントラスト法ないしコントラスト構成に使用される。
Patent JP-2002500761-A (JP)
Title: 車両タイヤの圧力低下検出方法
IPC: B60C23/06
Filed: 1998-05-19
Abstract: (57)【要約】
本発明は、車両タイヤの圧力低下を検出するための方法に関する。この場合、複数の車輪の車輪回転速度を示す（ステップ１０１）信号、特に時間測定値から、基準値が求められ（ステップ１０３）、今決定された基準値を少なくとも１つの比較値と比較することによって、今決定された基準値が比較値を上回っているかまたは下回っているときに（ステップ１０５）、圧力低下が推測される。車両タイヤの圧力低下の検出が少なくとも１つの基準値を用いて行われ、この基準値が、車輪回転速度を示す各々２つの信号の合計を割算することによって求められる。
Patent MD-20010146-A (MD)
Title: Fan (variants)
Inventor: BURCIU VITALIE
IPC: F04D25/08
Filed: 2001-05-15
Abstract: The invention refers to the fans meant for ventilation of rooms.The fan contains a turbine provided with an air suction hole. The turbine is mounted onto a vertical shaft with the possibility of rotation about the axis of the shaft. The turbine shaft is supported in bearings. The shaft is composed of two parts: of a bar, onto the upper end of which it is fixed a ball, and of a pipe, installed with clearance onto the bar, at the same time into the bar there is made a radial channel. The pipe is provided with a fixing arm, entered with clearance into the radial channel of the bar. The turbine is made of a plate, fixed onto the upper end of the pipe. The plate is kinematically joined with the ball of the bar. The turbine also contains a ring, placed coaxial with the shaft at a certain distance from the plate, depending on the turbine diameter. The ring is fixed onto the pipe. The turbine is provided with blades, executed in the form of an isosceles triangle, the point of the blade angle is oriented towards the outside of the turbine. The other two angles of the turbine blades are respectively joined with the plate and with the ring of the turbine, the blades being bent in the form of U, V or W.
Patent MX-155666-A (MX)
Inventor: YAMADA HIROMI
IPC: H01R12/71
Filed: 1984-11-14
Abstract: A low profile electrical connector assembly comprises matable first and second dielectric housing members having first and second matable electrical contacts secured respectively therein. The first electrical contact comprises a resilient hooked contact portion disposed about a supporting rib extending from a wall in the first housing member in the mating direction. The second electrical contact comprises a base plate which extends parallel to the mating direction and includes a conductor-connecting portion extending outwardly from the ends of the base plate from one side of the base plate and a contact portion extending outwardly from sides of the base plate from the other side of the base plate so that the contact portion resiliently engages the hooked contact portion in an interference fit when the housings mate together.
Patent NZ-210692-A (NZ)
Title: Multi-chamber diaphram pump driven by sequential air pulses
Inventor: LINDNER G H
IPC: F04B43/073
Filed: 1984-12-21
Abstract: A positive displacement pump (310) utilizes at leastthree driven displacer valves (360,362,364) and a plurality of driving membranes (336,340,344) and at least one pumping membrane (316) to withdraw minute quantities of corrosive fluid from a drum (100) and discharge same to a delivery point (128). The pump (310) is submerged within the fluid to be pumped and is driven by a remotely positioned pneumatic pulse generator (116) comprising pneumatic logic circuitry. The driven displacer valves (360,362,364) operate in a particular sequence to draw fluid into the pump body (312,314), advance same in succession through pumping chambers (318,320,322) within the pump body (312,314), and then discharge same at a constant rate of discrete pulses through an outlet port (332). The pulse generator (116) and logic circuitry provide the control pulses for operating the displacer valves (360,362,364) at the proper times in the operational cycle. The delivery characteristics of the pump far exceed the performance capabilities of conventional pumps utilized for similar purposes.
Patent NZ-226175-A (NZ)
Title: Non-slip insole base with raised ridges
Inventor: MISEVICH KENNETH W
IPC: A43B13/38
Filed: 1988-09-13
Abstract: An insole base member in planar form for providing a mechanical interlock with a shoe insole is disclosed. The insole base provides a low volume, low profile molded pattern which contacts the underside of the insole material and prevents shearing shifts of the insole. In one embodiment, the insole base has a smooth upper surface in the region adjacent the metatarsal heads of the foot, with a plurality of raised ridges extending transversely across the smooth upper surface, and with the upper surface of the insole base having a cross hatch pattern extending over the remainder of the base anterior and posterior to the smooth upper surface portion. The raised ridges may be positioned so as to lie parallel to the transverse and oblique metatarsal axes of the foot. In alternative embodiments, a plurality of raised ridges are positioned adjacent to the heel or the ball of the foot, with such raised ridges being located outwardly of a central reference point in a pattern corresponding to the spokes of a wheel.
Patent NZ-229279-A (NZ)
Title: Water heating and aerating device for coffee machine: air pockets above water channels
Inventor: FRISCH MARTIN
IPC: A47J31/36
Filed: 1989-05-25
Abstract: This device is arranged between a pump body and an extraction system and comprises a horizontal heating body (17) and a water circulation circuit (3,5,7,9,11,13,15), the said circuit comprising water circulation ducts and pockets for the retention of air, situated above the normal water level. Air can thus be dissolved in the water in order to provide an espresso coffee having lasting froth. 
<IMAGE>
Patent NZ-241568-A (NZ)
Title: Amide, sulphonamide and phosphonamide derivatives and pharmaceutical compositions
Inventor: VINCENT MICHEL
IPC: C07D207/16
Filed: 1992-02-10
Abstract: Compounds of formula (I): 
<IMAGE>
 which can be used as N-myristoyltransferase inhibitors, in which 
 
  R1 represents a hydrogen atom, a substituted or unsubstituted (C1-C6) alkyl group, substituted or unsubstituted phenyl, (C3-C7) cycloalkylmethyl, substituted or unsubstituted (2-imidazolyl)methyl, substituted or unsubstituted (3-indolyl)methyl or (1-aza-2-indolizinyl)methyl, 
  R2 and R3, which are identical or different, represent a hydrogen atom or a (C1-C6) alkyl group, or else, when R1 represents a hydrogen atom, R2 and R3 form, with the carbon and nitrogen atoms to which they are attached, a mono-, bi- or tricyclic heterocycle, 
  X represents a -CO-, -SO2-, or -PO(OH)- group, 
  Y represents a -COR5 or -POR6R6' group, 
  R4 represents a linear or branched, substituted or unsubstituted (C6-C21) alkyl group in which, according to the case, one or more methylene groups can be replaced by an oxygen or sulphur atom or a p-phenylene nucleus, 
 their isomers, diastereoisomers and epimers as well as their addition salts with a pharmaceutically acceptable acid or base. 
<??>Medicaments.
Patent NZ-244141-A (NZ)
Title: Compositions for parenteral administration comprising more than one
Inventor: HOLT JOHN ALFRED GORTON
IPC: A61P35/00
Filed: 1992-08-28
Abstract: A method of cancer therapy comprises administering to a patient a non-toxic agent selected from organic disulfides (e.g. cystine or penicillamine disulfide), oxidising agents (e.g. cumene hydroperoxide or t-butyl hydroperoxide) and organic sulfoximines (e.g. methionine sulfoximine), and while the agent (or more than one of the agents) is/are present at a cancer site of the patient administering to the cancer site an effective dose of microwave electromagnetic radiation of frequency in the range of about 400-450 MHz, preferably in the range of about 432-436 MHz.
Patent NZ-248013-A (NZ)
Title: 3,4,5-substituted benzoylguanidines, preparation and pharmaceutical compositions thereof
Inventor: WEICHERT ANDREAS
IPC: C07C315/04
Filed: 1993-06-29
Abstract: Benzoylguanidines of the formula I <IMAGE>  with   R(1) equal to R(4)-SOm or R(5)R(6)N-SO2- with R(4) and R(5) equal to alk(en)yl, -CnH2n-R(7), and with R(7) equal to cycloalkyl or phenyl, where R(5) can also mean H, R(6) equals H or C1-C4-alkyl,   R(2) is hydrogen, (cyclo)alk(en)(yn)yl, aryl and hetaryl   R(3) is defined as R(2),  and their pharmaceutically tolerated salts, are described. Compounds I are obtained by reacting compounds of the formula II <IMAGE> with guanidine, in which L is a leaving group which can easily undergo nuclophilic substitution. Compounds I are outstandingly suitable as antiarrhythmic drugs with cardioprotective component for the treatment and prophylaxis of infarct and for treating angina pectoris, and they also greatly reduce preventively the pathophysiological processes in the development of ischaemia-induced damage. Furthermore, I are distinguished by a potent inhibitory action on cell proliferation. They can thus be used as antiatherosclerotics, remedies for the late complications of diabetes, cancers, fibrotic disorders such as pulmonary, hepatic or renal fibrosis. They are effective inhibitors of the cellular sodium-proton antiporter (Na<+>/H<+> exchanger).
Patent NZ-310850-A (NZ)
Title: 3 alpha hydroxy(17)-unsubstituted derivatives of androstane and 21 substituted derivatives of the pregnane series and medicaments
Inventor: UPASANI RAVINDRA
IPC: C07J1/00
Filed: 1996-06-06
Abstract: The invention relates to a 3 alpha -hydroxy, 17-(un)substituted derivatives of the androstane series and 3 alpha -hydroxy, 21-substituted derivatives of the pregnane series. These derivatives are capable of acting at the recently identified site on the GRC, thereby modulating brain excitability in a manner that will alleviate stress, anxiety, insomnia, mood disorders that are amenable to GRC-active agents (such as depression) and seizure activity. The steroid derivatives of this invention are those having general structural formula (I), wherein R, R1, R2, R3,R4, R5, R6, R7, R8, R9 and R10 are further defined herein and the dotted lines are single or double bonds. The structure includes androstanes pregnanes (R4 = methyl), 19-norandrostanes, and norpregnanes (R4=H). <IMAGE>
Patent NZ-334371-A (NZ)
Title: Production of refrigerated filled or non-filled pasta by coating with salt and steaming, with predetermined water activity and final weight
Inventor: HSU JAU YANN
IPC: A23L7/109
Filed: 1999-02-25
Abstract: A process is disclosed for the production of a refrigerated filled or non-filled pasta which consists of coating either the dough shell of a raw filled pasta or a non-filled raw pasta with salt to obtain a water activity of from 0.85 to 0.94, steaming the salt -coated pasta to give a moisture content of the pasta dough of from 30 to 40% by weight, and packaging the pasta under modified atmospheric or vacuum conditions.
Patent NZ-336371-A (NZ)
Title: Human gene therapy using DNA/RNA cassette expression systems
Inventor: GAGNE MARC
IPC: C12N15/55
Filed: 1996-05-10
Abstract: Use of a recombinant DNA expression system comprising a 5' expression regulation DNA sequence and a decretory DNA and a secretory DNA sequence encoding a secretory signal sequence operatively linked to a DNA sequence encoding for  therapeutic protein, peptide o antisense nucleotide selected from the group consisting of bacteriocins, lanthionins, lactoferrin and lysosyme, wherein said expression regulation DNA sequence and said secretory DNA sequence are capable of directing the in vivo expression of said DNA sequence of a therapeutically effective amount of said protein, peptide or antisense nucleotide as a active ingredient in a composition to prevent or treat an infectious disease in a human.
Patent NZ-504674-A (NZ)
Title: Insulated cable, coloured fibres wound around conductors, which are then covered with transparent insulation layer
Inventor: TSAI CHENG-LANG
IPC: H01B7/36
Filed: 2000-05-19
Abstract: An insulated cable includes conductors 21 which may be wound around a guide wire 1.  A colored filament layer 3 is uniformly wound around the conductors.  A transparent plastic sheath is then extruded over the filament layer.  The filament layer may consist of several different colored filaments, and two or more conductors may be combined in the same transparent sheath.  This arrangement allows the conductors to be color coded without having to change the color of the sheath.
Patent NZ-508059-A (NZ)
Title: Use of APO B secretion/MTP inhibitors to reduce intestinal fat absorption
Inventor: LUNDY KRISTIN MARIE
IPC: A61P3/04
Filed: 2000-11-09
Abstract: A method of reducing intestinal fat absorption in an animal comprises administering an intestinal fat absorption-reducing amount of an apolipoprotein B secretion/microsomal trigyceride transfer protein inhibitor and optionally an antiobesity agent to the animal. A composition containing an apolipoprotein B secretion/microsomal trigyceride transfer protein inhibitor and an antiobesity agent is described. The apolipoprotein B secretion/microsomal trigyceride transfer protein inhibitor (or the stereoisomers and hydrates thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers and hydrates) can have the formula (I) wherein L is X-Y-Z or G; X is CH2, CO, CS, or SO2; Y is a direct link, optionally substituted aliphatic hydrocarbylene radicals radical, NH, or O; provided that if X is CH2, Y is a direct link; and Z is hydrogen, halogen, cyano, hydroxy, alkoxy, alkylthio, acyl, thiophenylcarbonyl, alkoxycarbonyl, aryloxy, arylthio, arylalkoxy, arylalkylthio, cycloalkyloxy, cycloalkenyloxy or provided that Y is not O or NH Z is alkylamino, dialkylamino, arylalkylamino, or provided that if X is CH2, Z is H or is unsubstituted vinyl, aryl, cycloalkyl and fused benzo derivatives thereof, polycycloalkyl, cycloalkenyl, polycycloalkenyl or 5 to 14 membered optionally saturated monocyclic or fused polycyclic heterocyclic ring system containing a total of from 1 to 4 ring heteroatoms selected from oxygen, nitrogen, or sulphur and when Z contains one or more rings, the  rings may each independently bear 0 to 4 substituents and G is optionally substituted phenyl or 3 to 14 membered optionally saturated monocyclic or fused polycyclic heterocyclic ring system containing a total of from 1 to 4 ring heteroatoms selected from oxygen, nitrogen, or sulphur or G is -CH2-CN, optionally substituted alkyl,  perfluoroalkyl, cycloalkyl, cycloalkenyl or -(CH2)n-COR4; can be the compound 9-[4-[4-(2,3-dihydro-1-oxo-1H-isoindol-2-yl)-1-piperidinyl]butyl]-N-propyl-9H-fluorene-9-carboxamide, and the pharmaceutically acceptable salts thereof or the compound 2-[1-(3,3-diphenylpropyl)-4-piperidinyl]-2,3-dihydro-1H-isoindol-1-one or pharmaceutically acceptable salts thereof and the compound 9-[4-(4-[2-(4-trifluoromethylphenyl)benzoylamino]piperidin-1-yl)butyl]-N-2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide and the pharmaceutically acceptable salts thereof.
Patent NZ-508461-A (NZ)
Title: Automated pharmaceutical management and dispensing system for overjacketed packages having indicia and a configuration corresponding to a unit dose
Inventor: AHLIN ARNOLD C
IPC: G16H40/63
Filed: 1999-05-26
Abstract: The system for automatically dispensing medications or other medical elements includes several groupings, i.e. vaults, of storage members, each vault containing approximately 100 individual cartridges, which each contain packages of unit-of-use doses of a given medication or other medical supply, such as syringes. Each storage member includes an ejector which ejects selected medications/supplies to a supply trough. The packages in the trough are moved to a central collator, which dispenses them to a bin receptacle which has been moved underneath the collator and which is typically identified with a particular patient. Information concerning medications/supplies for a particular patient is stored in a system database and used to determine the particular medications/supplies dispensed into a given bin. Bar coding is used to maintain control over the bins, and the medications, forming a closed information/control system. Particular medications and/or supplies which are not available in the automatic dispensing system are supplied from a supplemental medications cart which has been previously stocked with the correct additional medications by virtue of information from a control computer. The filled bins are transferred to a medication cart which can only be accessed as a result of a command signal after a particular patient and his/her associated bin have been matched. A nurse, having access to the correct bin and sector thereof, removes the medications from the cart and administers them to the patient.
Patent NZ-509239-A (NZ)
Title: 2-(4-(N-salicyloyl)aminophenyl)propionic acid useful as a carrier in compositions for delivering active agents
Inventor: LEONE-BAY ANDREA
IPC: A61K38/095
Filed: 1999-07-27
Abstract: A compound of formula (I) is useful as a carrier for the delivery of pharmaceutically active agents.
Patent NZ-509249-A (NZ)
Title: Constructional support for buildings has three guide members secured to a load bearing support in an equilateral triangular configuration and each guide members has a passage for receiving tubular anchors in a snug fit
Inventor: LAWSON ROBERT
IPC: E02D5/38
Filed: 1999-07-02
Abstract: A constructional support including three tubes secured to a central support member with the tubes defining guides for drilling holes into the ground and for guiding anchor members as they are being driven into the holes to secure the support with respect to the ground. In one embodiment, the longitudinal axes of the tubes intersect at a point along the longitudinal axis of the central support member. In another embodiment, the longitudinal axes of the tubes each lie in a respective plane which is parallel to the longitudinal axis of the central support member
Patent NZ-509975-A (NZ)
Title: Apparatus for coating confections, possibly with marbled-appearance
Inventor: BUSSE KURT
IPC: B05C5/02
Filed: 1999-08-18
Abstract: A chocolate coating apparatus for producing a chocolate coating for confectionary (e.g. cakes, ice cream, etc) having a marbled appearance has an inlet 26 for supplying liquid chocolate and at least one positioning device 20 for receiving the chocolate and directing the stream onto the confectionary in a desired pattern using centrifugal force. The positioning device is powered so that it rotates at a constant speed and has at least one rotatable cup 22 or pipe that incorporates an overflow channel to control the output of chocolate coating and to aid recirculation of chocolate that does not adhere to the surface of the confectionary.
Patent NZ-512324-A (NZ)
Title: Hypodermic syringe with a retractable needle
Inventor: HOECK ROGER
IPC: A61M5/50
Filed: 2001-06-13
Abstract: A hypodermic needle syringe with a selectively retractable needle includes: an elongate barrel defining a receiver and a hollow bore; a plunger divided into a proximal and distal portion joined by an attachment; a stopper located at the distal end of the plunger; an elongate sleeve extending from the proximal portion of the plunger to the stopper containing cutting surfaces; an elongate hub with a proximal flange; an elongate spring; and elongate needle with a pointed distal end and a mounted proximal end.  The plunger is sized to fit within the bore of the barrel for a slidable movement to define a chamber for receiving and expelling fluids.  The distal portion of the plunger contains a stopper sized to form a slidably substantially fluid tight seal with the bore of the barrel.  The spring is disposed about the hub and is compressed between the receiver and flange to provide a bias.  The receiver and barrel are sized to allow slidable movement of the hub, while retaining the spring about the hub.  When a distal force greater than that required to expel fluid is placed on the plunger, the attachment between the distal and proximal portions of the plunger is frangibly disrupted thereby collapsing the distal portion into the proximal portion.  The cutting surfaces of the sleeve cuts through the stopper and flange thereby releasing the hub from the receiver and allowing the spring to urge a sufficient movement of the hub to a position within the syringe where inadvertent contact with the needle is substantially prevented.  (For explanation of notations on figure, refer to complete specification).
Patent NZ-513297-A (NZ)
Title: C10 ester substituted taxol derivatives useful for inhibiting tumour growth
Inventor: HOLTON ROBERT A
IPC: A61K31/341
Filed: 2001-08-01
Abstract: A taxane of formula (I) are described wherein: R2 is acyloxy R7 is hydroxy R9 is keto, hydroxy or acyloxy R10 is R10aCOO- R10a is hydrocarbyl, substituted hydrocarbyl or heterocyclo wherein the hydrocarbyl or substituted hydrocarbyl contains carbon atoms in the alpha and beta positions relative to the carbon atoms of which R10a is a substituent; R14 is hydrido or hydroxy; X3 is substituted or unsubstituted heterocyclo; X5 is -COX10, -COOX10, or -CONHX10; X10 is hydrocarbyl, substituted hydrocarbyl or heterocyclo; and Ac is acetyl; or wherein R2 is benzoyloxy; R9 is hydroxy; R14 is H, X3 is substituted or unsubstituted alkyl, alkenyl, alkynyl or heterocyclo; X5 is -COX10, X10 is substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl or heterocyclo; and R7, R10, R10a, and Ac are as above; or wherein R2 is benzoyloxy; R9 is keto; R14 is hydrido, X3 is furyl, thienyl or pyridyl; X5 is -COX10, X10 is phenyl or -COOX10 wherein X10 is t-butyl; R10a is ethyl, propyl or cyclopropyl and R7, R10, and Ac are as above. The taxanes can be used in the manufacture of a pharmaceutical composition for inhibiting tumor growth.
Patent NZ-517369-A (NZ)
Title: Method for the production of adrenaline
Inventor: KLINGLER FRANZ DIETRICH
IPC: C07C213/00
Filed: 2000-08-04
Abstract: A process for preparing adrenaline or an addition salt of adrenaline from an N-protected adrenalone, comprises: (a) subjecting the N-protected adrenalone to asymmetric hydrogenation with [Rh(COD)Cl]2 and a chiral, bidentate phosphine ligand as a catalyst system to obtain an N- protected adrenaline; (b) precipitating the N-protected adrenaline in the basic range; and (c) cleaving the N-protecting group of the precipitated N- protected adrenaline in the acid range to obtain adrenaline or an addition salt of adrenaline.
Patent NZ-518746-A (NZ)
Title: Paint door stand having capability of fully rotating the door around a vertical axis for painting
Inventor: LOMAX GRANT RAYMOND
IPC: B05C13/02
Filed: 2002-05-06
Abstract: A fixture is disclosed to support an article such as a door (1) for painting. The fixture firstly has a first and second spaced, aligned supports (7, 7'), where the free ends of the supports disposed in facing opposed relation. Clamping means (16) are provided to engage the central area of the opposed edges of the door (1). This way, the door is allowed to pivot about a vertical axis (8). The door can be painted by firstly painting one side, rotating the door about its axis (8), and painting the other side without lifting the door, or having to walk around the door.
Patent NZ-519127-A (NZ)
Title: A method of manufacturing frozen dairy dessert
Inventor: MEHTA NIRANJAN CHHOTALAL
IPC: A23G9/32
Filed: 2000-12-21
Abstract: The invention describes the manufacture of a frozen dessert, akin to sorbet, but having the organoleptic properties of ice cream from cooled milk whey. The milk whey could contain desired amount of fat, ranging from little to no fat, depending upon the quality and caloric value of the end product desired. Suitable sweetening agents and binders are added to the whey which is subjected to a process of simultaneous agitation, aeration and freezing, resulting in a frozen dessert with an over run.